Advertisement
Screener

TECTONIC THERAPEUTIC, INC. (TECX) Deferred Tax Assets, Operating Loss Carryforwards, Not Subject to Expiration

2.1 / 5 stars · 19/46 Roast Me

TECTONIC THERAPEUTIC, INC. Deferred Tax Assets, Operating Loss Carryforwards, Not Subject to Expiration

TECTONIC THERAPEUTIC, INC. (TECX) had Deferred Tax Assets, Operating Loss Carryforwards, Not Subject to Expiration of $399.30 million as of 2024-12-31, per its 10-K filed 2025-03-20.

Financial Statements › Notes › Components of Deferred Tax Assets and Liabilities › Components of Deferred Tax Assets › Deferred Tax Assets, Net › Deferred Tax Assets, Net of Valuation Allowance › Deferred Tax Assets, Gross

us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsNotSubjectToExpiration · last filed 2025-03-20

  • 2024-12-31: Deferred Tax Assets, Operating Loss Carryforwards, Not Subject to Expiration $399.30M.
  • 2022-12-31: Deferred Tax Assets, Operating Loss Carryforwards, Not Subject to Expiration $322.61M.
  • 2021-12-31: Deferred Tax Assets, Operating Loss Carryforwards, Not Subject to Expiration $295.22M.
  • 2020-12-31: Deferred Tax Assets, Operating Loss Carryforwards, Not Subject to Expiration $196.25M.
Period endDeferred Tax Assets, Operating Loss Carryforwards, Not Subject to Expiration
2024-12-31$399.30M
10-K · filed 2025-03-20
2022-12-31$322.61M
10-K · filed 2023-03-23
2021-12-31$295.22M
10-K · filed 2022-03-17
2020-12-31$196.25M
10-K · filed 2021-03-18
2019-12-31$104.09M
10-K · filed 2020-03-16
2018-12-31$39.77M
10-K · filed 2019-03-25

Similar stocks

Stock NameCountryMarket CapPE Ratio
REGENXBIO Inc. (RGNX)United States$0.477B-3.30
Entera Bio Ltd. (ENTX)$0.485B
Eikon Therapeutics, Inc. (EIKN)United States$0.446B
Kyverna Therapeutics, Inc. (KYTX)United States$0.434B-3.60
Autolus Therapeutics plc (AUTL)$0.506B-1.52
Editas Medicine, Inc. (EDIT)United States$0.424B-4.29
Scribe Therapeutics, Inc. (SCTX)United States$0.410B
Zura Bio Ltd (ZURA)$0.398B-6.56
Surrozen, Inc./DE (SRZN)United States$0.395B
AGENUS INC (AGEN)United States$0.383B1.41